United Kingdom Drug Delivery Devices Market Outlook to 2023-Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

United Kingdom Drug Delivery Devices Market Outlook to 2023-Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices


  • Products Id :- GDMEMC0242DB
  • |
  • Pages: 260
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

United Kingdom Drug Delivery Devices Market Outlook to 2023-Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

Summary

GlobalData's new report, "United Kingdom Drug Delivery Devices Market Outlook to 2023", provides key market data on the United Kingdom Drug Delivery Devices market. The report provides value, in millions of US dollars and volume (in units) within market categories-Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

Market size and company share data for Drug Delivery Devices market categories-Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.

Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2009 to 2016 and forecast to 2023.

2016 company shares and distribution shares data for each of the market categories.

Global corporate-level profiles of key companies operating within the United Kingdom Drug Delivery Devices market.

Key players covered include GlaxoSmithKline Plc, AstraZeneca Plc, Hospira Inc, Becton Dickinson and Co, Boehringer Ingelheim GmbH, Baxter International Inc, Medtronic plc and others.

Reasons to buy

Develop business strategies by identifying the key market categories poised for strong growth in the future.

Develop market-entry and market expansion strategies.

Design competition strategies by identifying who-stands-where in the market.

Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.

What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 6

2 Introduction 7

2.1 What Is This Report About? 7

2.2 Drug Delivery Devices Market Segmentation 7

2.3 Definitions of Markets Covered in the Report 8

3 Drug Delivery Devices Market, United Kingdom 11

3.1 Drug Delivery Devices Market, United Kingdom, Revenue ($m), 2009-2023 11

3.2 Drug Delivery Devices Market, United Kingdom, Revenue Mix ($m), 2016 13

3.3 Drug Delivery Devices Market, United Kingdom, Category Contribution by Revenue ($m), 2016 14

3.4 Drug Delivery Devices Market, United Kingdom, Category Comparison by Revenue ($m), 2009-2023 15

3.5 Drug Delivery Devices Market, United Kingdom, Revenue ($m), 2009-2016 17

3.6 Drug Delivery Devices Market, United Kingdom, Revenue ($m), 2016-2023 19

3.7 Drug Delivery Devices Market, United Kingdom, Volume (Units), 2009-2023 21

3.8 Drug Delivery Devices Market, United Kingdom, Volume (Units), 2009-2016 23

3.9 Drug Delivery Devices Market, United Kingdom, Volume (Units), 2016-2023 25

3.10 Drug Delivery Devices Market, United Kingdom, Company Share by Revenue ($m), 2016 27

4 Central Venous Catheters Market, United Kingdom 29

4.1 Central Venous Catheters Market, United Kingdom, Revenue Mix ($m), 2016 29

4.2 Central Venous Catheters Market, United Kingdom, Segment Contribution (%), 2016 30

4.3 Central Venous Catheters Market, United Kingdom, Revenue ($m), 2009-2016 31

4.4 Central Venous Catheters Market, United Kingdom, Revenue ($m), 2016-2023 33

4.5 Central Venous Catheters Market, United Kingdom, Volume (Units), 2009-2016 35

4.6 Central Venous Catheters Market, United Kingdom, Volume (Units), 2016-2023 37

4.7 Central Venous Catheters Market, United Kingdom, Distribution Share by Revenue ($m), 2015-2016 39

4.8 Central Venous Catheters Market, United Kingdom, Company Share by Revenue ($m), 2016 40

5 Infusion Systems Market, United Kingdom 42

5.1 Infusion Systems Market, United Kingdom, Revenue Mix ($m), 2016 42

5.2 Infusion Systems Market, United Kingdom, Segment Contribution (%), 2016 43

5.3 Infusion Systems Market, United Kingdom, Revenue ($m), 2009-2016 45

5.4 Infusion Systems Market, United Kingdom, Revenue ($m), 2016-2023 47

5.5 Infusion Systems Market, United Kingdom, Volume (Units), 2009-2016 57

5.6 Infusion Systems Market, United Kingdom, Volume (Units), 2016-2023 59

5.7 Infusion Systems Market, United Kingdom, Distribution Share by Revenue ($m), 2015-2016 69

5.8 Infusion Systems Market, United Kingdom, Company Share by Revenue ($m), 2016 70

6 Needle Free Injections Market, United Kingdom 72

6.1 Needle Free Injections Market, United Kingdom, Revenue ($m), 2009-2016 72

6.2 Needle Free Injections Market, United Kingdom, Revenue ($m), 2016-2023 73

6.3 Needle Free Injections Market, United Kingdom, Volume (Units), 2009-2016 74

6.4 Needle Free Injections Market, United Kingdom, Volume (Units), 2016-2023 75

6.5 Needle Free Injections Market, United Kingdom, Distribution Share by Revenue ($m), 2015-2016 76

6.6 Needle Free Injections Market, United Kingdom, Company Share by Revenue ($m), 2016 77

7 Metered Dose Inhaler Devices Market, United Kingdom 79

7.1 Metered Dose Inhaler Devices Market, United Kingdom, Revenue ($m), 2009-2016 79

7.2 Metered Dose Inhaler Devices Market, United Kingdom, Revenue ($m), 2016-2023 80

7.3 Metered Dose Inhaler Devices Market, United Kingdom, Volume (Units), 2009-2016 81

7.4 Metered Dose Inhaler Devices Market, United Kingdom, Volume (Units), 2016-2023 82

7.5 Metered Dose Inhaler Devices Market, United Kingdom, Distribution Share by Revenue ($m), 2015-2016 83

7.6 Metered Dose Inhaler Devices Market, United Kingdom, Company Share by Revenue ($m), 2016 84

8 Overview of Key Companies in United Kingdom, Drug Delivery Devices Market 86

8.1 B. Braun Melsungen AG 86

8.2 Teleflex Inc 86

8.3 GlaxoSmithKline Plc 86

8.4 Baxter International Inc 87

8.5 AstraZeneca Plc 87

8.6 Boehringer Ingelheim GmbH 87

8.7 Pfizer Inc 87

8.8 Becton Dickinson and Co 88

8.9 Smiths Medical 88

8.10 Merck & Co Inc 88

8.11 Fresenius Kabi AG 89

8.12 Medtronic Plc 89

8.13 Hospira Inc 89

8.14 Terumo Corp 89

9 Drug Delivery Devices Market Pipeline Products 90

10 Financial Deals Landscape 96

10.1 Acquisition 96

10.2 Asset Transactions 98

10.3 Debt Offerings 100

10.4 Equity Offerings 101

10.5 Partnerships 103

10.6 Venture Financing 118

11 Recent Developments 123

11.1 Corporate Communications 123

11.2 Financial Announcements 148

11.3 Legal And Regulatory 239

11.4 Other Significant Developments 240

11.5 Product News 245

11.6 Strategy And Business Planning 246

12 Appendix 252

12.1 Research Methodology 253

12.2 GlobalData Consulting 255

12.3 Contact Us 256

12.4 Disclaimer 256

1.2 List of Figures

Figure 1: Drug Delivery Devices Market, United Kingdom, Revenue ($m), USD Constant, 2009-2023 15

Figure 2: Drug Delivery Devices Market, United Kingdom, Revenue Mix ($m), 2016 17

Figure 3: Drug Delivery Devices Market, United Kingdom, Category Contribution (%), 2016 18

Figure 4: Drug Delivery Devices Market, United Kingdom, Category Comparison by Revenue ($m), 2009-2023 19

Figure 5: Drug Delivery Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 21

Figure 6: Drug Delivery Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 23

Figure 7: Drug Delivery Devices Market, United Kingdom, Volume (Units), 2009-2023 25

Figure 8: Drug Delivery Devices Market, United Kingdom, Volume (Units), Historic, 2009-2016 27

Figure 9: Drug Delivery Devices Market, United Kingdom, Volume (Units), Forecast, 2016-2023 29

Figure 10: Drug Delivery Devices Market, United Kingdom, Company Share (%) 2016 31

Figure 11: Central Venous Catheters Market, United Kingdom, Revenue Mix ($m), 2016 33

Figure 12: Central Venous Catheters Market, United Kingdom, Segment Contribution (%), 2016 34

Figure 13: Central Venous Catheters Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 35

Figure 14: Central Venous Catheters Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 37

Figure 15: Central Venous Catheters Market, United Kingdom, Volume (Units), Historic, 2009-2016 39

Figure 16: Central Venous Catheters Market, United Kingdom, Volume (Units), Forecast, 2016-2023 41

Figure 17: Central Venous Catheters Market, United Kingdom, Company Share (%) 2016 44

Figure 18: Infusion Systems Market, United Kingdom, Revenue Mix ($m), 2016 46

Figure 19: Infusion Systems Market, United Kingdom, Segment Contribution (%), 2016 47

Figure 20: Infusion Systems Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 49

Figure 21: Infusion Systems Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 51

Figure 22: Ambulatory Infusion Pumps Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 53

Figure 23: Syringe Pumps Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 55

Figure 24: Ambulatory Infusion Pumps Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 57

Figure 25: Syringe Pumps Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 59

Figure 26: Infusion Systems Market, United Kingdom, Volume (Units), Historic, 2009-2016 61

Figure 27: Infusion Systems Market, United Kingdom, Volume (Units), Forecast, 2016-2023 63

Figure 28: Ambulatory Infusion Pumps Market, United Kingdom, Volume (Units), Historic, 2009-2016 65

Figure 29: Syringe Pumps Market, United Kingdom, Volume (Units), Historic, 2009-2016 67

Figure 30: Ambulatory Infusion Pumps Market, United Kingdom, Volume (Units), Forecast, 2016-2023 69

Figure 31: Syringe Pumps Market, United Kingdom, Volume (Units), Forecast, 2016-2023 71

Figure 32: Infusion Systems Market, United Kingdom, Company Share (%) 2016 74

Figure 33: Needle Free Injections Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 76

Figure 34: Needle Free Injections Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 77

Figure 35: Needle Free Injections Market, United Kingdom, Volume (Units), Historic, 2009-2016 78

Figure 36: Needle Free Injections Market, United Kingdom, Volume (Units), Forecast, 2016-2023 79

Figure 37: Needle Free Injections Market, United Kingdom, Company Share (%) 2016 81

Figure 38: Metered Dose Inhaler Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 83

Figure 39: Metered Dose Inhaler Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 84

Figure 40: Metered Dose Inhaler Devices Market, United Kingdom, Volume (Units), Historic, 2009-2016 85

Figure 41: Metered Dose Inhaler Devices Market, United Kingdom, Volume (Units), Forecast, 2016-2023 86

Figure 42: Metered Dose Inhaler Devices Market, United Kingdom, Company Share (%) 2016 88

1.1 List of Tables

Table 1: Drug Delivery Devices Market, United Kingdom, Revenue ($m), USD Constant, 2009-2023 16

Table 2: Drug Delivery Devices Market, United Kingdom, Category Contribution by Revenue ($m), 2016 18

Table 3: Drug Delivery Devices Market, United Kingdom, Category Comparison by Revenue ($m), 2009-2023 20

Table 4: Drug Delivery Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 22

Table 5: Drug Delivery Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 24

Table 6: Drug Delivery Devices Market, United Kingdom, Volume (Units), 2009-2023 26

Table 7: Drug Delivery Devices Market, United Kingdom, Volume (Units), Historic, 2009-2016 28

Table 8: Drug Delivery Devices Market, United Kingdom, Volume (Units), Forecast, 2016-2023 30

Table 9: Drug Delivery Devices Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2016 32

Table 10: Central Venous Catheters Market, United Kingdom, Segment Contribution (%), 2016 34

Table 11: Central Venous Catheters Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 36

Table 12: Central Venous Catheters Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 38

Table 13: Central Venous Catheters Market, United Kingdom, Volume (Units), Historic, 2009-2016 40

Table 14: Central Venous Catheters Market, United Kingdom, Volume (Units), Forecast, 2016-2023 42

Table 15: Central Venous Catheters Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2015-2016 43

Table 16: Central Venous Catheters Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2016 45

Table 17: Infusion Systems Market, United Kingdom, Segment Contribution (%), 2016 48

Table 18: Infusion Systems Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 50

Table 19: Infusion Systems Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 52

Table 20: Ambulatory Infusion Pumps Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 54

Table 21: Syringe Pumps Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 56

Table 22: Ambulatory Infusion Pumps Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 58

Table 23: Syringe Pumps Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 60

Table 24: Infusion Systems Market, United Kingdom, Volume (Units), Historic, 2009-2016 62

Table 25: Infusion Systems Market, United Kingdom, Volume (Units), Forecast, 2016-2023 64

Table 26: Ambulatory Infusion Pumps Market, United Kingdom, Volume (Units), Historic, 2009-2016 66

Table 27: Syringe Pumps Market, United Kingdom, Volume (Units), Historic, 2009-2016 68

Table 28: Ambulatory Infusion Pumps Market, United Kingdom, Volume (Units), Forecast, 2016-2023 70

Table 29: Syringe Pumps Market, United Kingdom, Volume (Units), Forecast, 2016-2023 72

Table 30: Infusion Systems Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2015-2016 73

Table 31: Infusion Systems Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2016 75

Table 32: Needle Free Injections Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 76

Table 33: Needle Free Injections Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 77

Table 34: Needle Free Injections Market, United Kingdom, Volume (Units), Historic, 2009-2016 78

Table 35: Needle Free Injections Market, United Kingdom, Volume (Units), Forecast, 2016-2023 79

Table 36: Needle Free Injections Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2015-2016 80

Table 37: Needle Free Injections Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2016 82

Table 38: Metered Dose Inhaler Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 83

Table 39: Metered Dose Inhaler Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 84

Table 40: Metered Dose Inhaler Devices Market, United Kingdom, Volume (Units), Historic, 2009-2016 85

Table 41: Metered Dose Inhaler Devices Market, United Kingdom, Volume (Units), Forecast, 2016-2023 86

Table 42: Metered Dose Inhaler Devices Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2015-2016 87

Table 43: Metered Dose Inhaler Devices Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2016 89

Table 44: Drug Delivery Devices Market Pipeline Products 94

Table 45: SMC Acquires Oval Medical Technologies 100

Table 46: GW Pharma May Sell Itself 101

Table 47: ICU Medical Acquires Hospira Infusion Systems Business from Pfizer 102

Table 48: Mylan Raises USD551.6 Million in Public Offering of Bonds Due 2020 104

Table 49: Nemaura Pharma to Raise up to USD6.2 Million in Equity Financing 105

Table 50: Midatech Pharma Raises USD19.8 Million in Private Placement of Shares 106

Table 51: Alimera Sciences Enters into Licensing Agreement with pSivida 107

Table 52: Bluegrass Vascular Enters into Partnership with Merit Medical 108

Table 53: Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 109

Table 54: Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 110

Table 55: Propeller Health Enters into Agreement with Novartis Pharma 112

Table 56: Neuronex Enters Into Licensing Agreement With SK Biopharmaceuticals For DZNS Technology 113

Table 57: Pfizer Terminates its Licensing Agreement with pSivida 114

Table 58: Clinigen Group Enters into Distribution Agreement with BioQ Pharma 115

Table 59: BioQ Pharma Enters into Agreement with Galen 116

Table 60: ITL Biomedical Enters into Distribution Agreement with bioMerieux Canada 117

Table 61: Herantis Pharma Enters into Agreement with Renishaw 118

Table 62: Bespak Europe Enters into Development Agreement with Biopharmaceutical Company 119

Table 63: Bayer Enters into Licensing Agreement with DelSiTech 120

Table 64: BioCorRx Enters into Licensing Agreement with Therakine 121

Table 65: Glide Technologies Raises USD4 Million in Venture Financing 122

Table 66: Glide Pharma Raises USD4 Million in Venture Financing 123

Table 67: Orthoson Raises Funds in Series B Equity Financing 124

Table 68: OxSonics Raises Funds in Series B Equity Financing 125

Table 69: Medherant Raises USD2 Million in Venture Financing 126

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

B. Braun Melsungen AG

Teleflex Inc

GlaxoSmithKline Plc

Baxter International Inc

AstraZeneca Plc

Boehringer Ingelheim GmbH

Pfizer Inc

Becton Dickinson and Co

Smiths Medical

Merck & Co Inc

Fresenius Kabi AG

Medtronic Plc

Hospira Inc

Terumo Corp

Drug Delivery Devices, Central Venous Catheters, Needle Free Injections, Infusion Systems, Metered Dose Inhaler Devices, Value (USD), Volume (units), Revenues, Historic Revenues, Forecast Revenues, Average Price, Company Share, Distribution Share by Revenue, Company Share by Revenue, Pipeline Products, News, Deals, Key Companies, GlaxoSmithKline Plc, AstraZeneca Plc, Boehringer Ingelheim GmbH, Pfizer Inc, Merck & Co Inc, Sunovion Pharmaceuticals Inc, Teva Pharmaceutical Industries Ltd, INJEX-Equidyne Systems, Bioject Medical Technologies Inc , Antares Pharma Inc, PharmaJet Inc, MK Global Co., The European Pharma Group, Hospira Inc, Becton Dickinson and Co, Baxter International Inc, Fresenius Kabi AG, Medtronic plc, B. Braun Melsungen AG, Terumo Corp, Smiths Medical, Nipro Corp, JMS Co Ltd

select a license

Single User License
USD 5995 INR 404363
Site License
USD 11990 INR 808726
Corporate User License
USD 17985 INR 1213088

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com